PharmaJet Poster Presentation at Cancer Immunotherapy Conference Highlights How Needle-free Technology is Enhancing Oncology ...

Umoja Biopharma, Inc. (Umoja), a transformative immunotherapy company creating off-the-shelf treatments that aim to extend the reach and effectiveness of CAR-T cell therapies in oncology and ...

Clinical update from ongoing MP0533 phase 1/2a dose escalation study confirms overall acceptable safety profile observed so far and initial ...

CHICAGO–(BUSINESS WIRE)–Tempus AI ... This year, highlights of Tempus’ poster presentations include: Poster Presentation ...

November 05, 2024--(BUSINESS WIRE)--ReAlta Life Sciences ... inflammatory response to address rare and acute inflammatory ...

On track to report topline data from Phase 2 TRANQUILITY trial in first half of 2025 – – Assembled Cardiovascular Scientific Advisory B ...

About NX-5948: NX-5948 is an investigational, orally bioavailable degrader of BTK that is currently being evaluated in a ...

CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology ... proprietary telomere-targeting THIO prodrugs has been accepted for poster presentation during the upcoming 36 th EORTC-NCI-AACR Symposium on ...

DIJON, France--(BUSINESS WIRE)--Regulatory News ... Professor of Gastroenterology at CHRU of Nancy. "This presentation provides strong evidence that OPM has the potential to advance the treatment ...

Posters will be made available on the Kineta website following presentations at the conference ... expectations and assumptions regarding the future of Kineta’s business, future plans and strategies, ...

Director Prasanth Varma unveils the first look of 'Jai Hanuman', the highly anticipated sequel to 'HanuMan', starring Rishab ...

Ten presentations (three oral and seven posters) from across its hematopoietic stem cell (HSC) gene therapy portfolio will be featured at the European Society of Gene and Cell Therapy (ESGCT) 31st ...